Lakefront Biotherapeutics (LKFT) Interest Coverage Ratio (QoQ) (2016 - 2026)
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Interest Coverage Ratio (QoQ) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 175,788.26% |
| Dec 31, 2025 | -100.07% |
| Sep 30, 2025 | 279.77% |
| Jun 30, 2025 | -52.04% |
| Mar 31, 2025 | 476,442.60% |
| Dec 31, 2024 | -100.02% |
| Sep 30, 2024 | -42.31% |
| Jun 30, 2024 | 221.32% |
| Mar 31, 2024 | 156,885.16% |
| Mar 31, 2023 | 4,138,769.06% |
| Jun 30, 2020 | 1,852.71% |
| Mar 31, 2020 | 34.07% |
| Dec 31, 2019 | 113.62% |
| Sep 30, 2019 | -133.75% |
| Jun 30, 2019 | 32.75% |
| Mar 31, 2019 | 415.43% |
| Dec 31, 2018 | 72.61% |
| Sep 30, 2018 | -332.33% |
| Jun 30, 2018 | -228.89% |
| Mar 31, 2018 | 141.18% |